Literature DB >> 24729313

Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.

Claudia Martelli1, Federica Iavarone, Federica Vincenzoni, Diana Valeria Rossetti, Luca D'Angelo, Gianpiero Tamburrini, Massimo Caldarelli, Concezio Di Rocco, Irene Messana, Massimo Castagnola, Claudia Desiderio.   

Abstract

The combination of top-down and bottom-up platforms was utilized for the LC-MS proteomic characterization of the intracystic fluid of adamantinomatous craniopharyngioma pediatric brain tumor disease. Proteins and peptides characterization was achieved by high-resolution LC-ESI-LTQ-Orbitrap-MS analysis while low-resolution LC-ESI-IT-MS was applied for the complete screening of the samples and the evaluation of the protein distribution within patients. Top-down analyses were applied to liquid/liquid extracted samples while bottom-up analyses were performed after trypsin digestion of both untreated and pretreated samples. The two proteomic approaches were complementary for the characterization of the proteome of craniopharyngioma intracystic fluid. Proteins and peptides involved in inflammation, mineralization processes and lipid transport were identified, in agreement with the calcium flecks, cholesterol granules and bone residues characteristic of this fluid. Apolipoprotein A-I, A-II, C-I and J, hemoglobin fragments, ubiquitin, α-2-HS-glycoprotein or fetuin A, α-1-antichymotrypsin, vitamin D binding protein, and α-1-acid glycoprotein were characterized. These data could be relevant for the comprehension of the processes involved in the pathogenesis of the disease and the development of the cyst and could contribute to the individuation of therapeutic targets for the reduction of the cyst volume delaying and/or avoiding invasive surgical treatments.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Brain tumor; Craniopharyngioma; Intracystic fluid; MS; Proteomics

Mesh:

Substances:

Year:  2014        PMID: 24729313     DOI: 10.1002/elps.201300578

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  12 in total

Review 1.  Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.

Authors:  Christopher Salvatore Graffeo; Avital Perry; Michael J Link; David J Daniels
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-19

Review 2.  Adamantinomatous craniopharyngioma: advances in proteomic research.

Authors:  Claudia Desiderio; Diana Valeria Rossetti; Massimo Castagnola; Luca Massimi; Gianpiero Tamburrini
Journal:  Childs Nerv Syst       Date:  2020-07-02       Impact factor: 1.475

3.  Prediction of calcification tendency in pediatric cystic adamantinomatous craniopharyngioma by using inflammatory markers, hormone markers, and radiological appearances.

Authors:  Ming Chen; Zhang Zhang; Min Yang; Shi-Ting Li
Journal:  Childs Nerv Syst       Date:  2019-05-07       Impact factor: 1.475

4.  Treatment of Cystic Craniopharyngiomas: An Update.

Authors:  Federico Bianchi; Alberto Benato; Luca Massimi
Journal:  Adv Tech Stand Neurosurg       Date:  2022

Review 5.  Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention.

Authors:  Christian L Roth
Journal:  J Clin Med       Date:  2015-09-09       Impact factor: 4.241

Review 6.  Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.

Authors:  Juan Pedro Martinez-Barbera
Journal:  Neuropathol Appl Neurobiol       Date:  2015-04-23       Impact factor: 8.090

Review 7.  Genetically engineered mouse models of craniopharyngioma: an opportunity for therapy development and understanding of tumor biology.

Authors:  John Richard Apps; Juan Pedro Martinez-Barbera
Journal:  Brain Pathol       Date:  2017-05       Impact factor: 6.508

8.  Proinflammatory macrophage-derived microvesicles exhibit tumor tropism dependent on CCL2/CCR2 signaling axis and promote drug delivery via SNARE-mediated membrane fusion.

Authors:  Ling Guo; Ye Zhang; Runxiu Wei; Xiaochen Zhang; Cuifeng Wang; Min Feng
Journal:  Theranostics       Date:  2020-05-17       Impact factor: 11.556

9.  Investigating the Protein Signature of Adamantinomatous Craniopharyngioma Pediatric Brain Tumor Tissue: Towards the Comprehension of Its Aggressive Behavior.

Authors:  Claudia Martelli; Riccardo Serra; Ilaria Inserra; Diana Valeria Rossetti; Federica Iavarone; Federica Vincenzoni; Massimo Castagnola; Andrea Urbani; Gianpiero Tamburrini; Massimo Caldarelli; Luca Massimi; Claudia Desiderio
Journal:  Dis Markers       Date:  2019-05-02       Impact factor: 3.434

10.  Activation of nuclear factor kappa B pathway and reduction of hypothalamic oxytocin following hypothalamic lesions.

Authors:  Christian L Roth; Gabrielle D'Ambrosio; Clinton Elfers
Journal:  J Syst Integr Neurosci       Date:  2016-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.